EP2462158

F. HOFFMANN-LA ROCHE AG
Application Number
EP10740823A
Filing Date
Aug 6, 2010
Status
Granted And Under Opposition
Dec 8, 2017
Grant Date
Jan 10, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2462158B1 was granted on Jan 10, 2018 by F. Hoffmann-La Roche Ag The patent is currently Granted And Under Opposition.

The table below shows 11 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BAYER INTELLECTUAL PROPERTY GMBH/BAYER PHARMA AKTIENGESELLSCHAFT/BAYER ANIMAL HEALTH GMBHOct 10, 2018ADMISSIBLE
LEEMING, JOHN GERARDOct 10, 2018ADMISSIBLE
MAIWALD GMBHOct 10, 2018ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBOct 10, 2018ADMISSIBLE
MORPHOSYS AGOct 10, 2018ADMISSIBLE
NEUEFEIND, REGINAOct 10, 2018ADMISSIBLE
POHLMAN, SANDRA M.Oct 10, 2018ADMISSIBLE
STRAWMAN LIMITEDOct 10, 2018ADMISSIBLE
KONIG SZYNKA TILMANN VON RENESSEOct 9, 2018ADMISSIBLE
POTTER CLARKSON LLPOct 9, 2018ADMISSIBLE
GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBBOct 4, 2018ADMISSIBLE

The table below shows the patents of F. Hoffmann-La Roche Ag that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3257564Overload And Elute ChromatographyMay 29, 20241
EP3294770Therapeutic And Diagnostic Methods For CancerMar 20, 20242
EP3998095Device For Sustained Delivery Of A Therapeutic FluidJan 31, 20241